2 active not recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia NNC4004-0002, Placebo - Healthy Volunteers, Hyperuricemia | Phase 1 | Active not recruiting | Novo Nordisk A/S | 50 | 2024-11-13 | 2026-10-26 |
| PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function SAP-001 - Gout, Hyperuricemia | Phase 1 / Phase 2 | Active not recruiting | Shanton Pharma Pte. Ltd. | 32 | 2024-04-24 | 2024-12-11 |
Gout (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arthritis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Crystal Arthropathies (1) · Genetic Diseases, Inborn (1) · Joint Diseases (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1) · Purine-Pyrimidine Metabolism, Inborn Errors (1) · Rheumatic Diseases (1)
Novo Nordisk A/S (1) · Shanton Pharma Pte. Ltd. (1)
United States (2)